Pfizer
Amoy Diagnostics, Pierre Fabre Collaborate to Develop CDx in China
The companion diagnostic kits will support marketing authorization applications for Pfizer's Braftovi and Mektovi.
The project involves numerous biopharmaceutical firms, including Pfizer, Roche, Takeda Pharmaceuticals, Sanofi, Novartis, ProQR Therapeutics, Lysogene, and Novo Nordisk.
The short oligo ligation assembly (SOLA) enzymatic DNA synthesis method uses a library of DNA building blocks to make oligos that are then assembled into genes.
The purchase of GeneDx from Opko Health will help Sema4 accelerate its push into whole-exome sequencing and grow in rare disease diagnostics.
Sema4 to Acquire GeneDx for $623M
While GeneDx parent Opko Health is essentially exiting the MDx business, it will pick up a "significant" stake in Sema4.